A study to assess effects of Regadenoson in patients with COPD or bronchial asthma
Latest Information Update: 02 Nov 2020
Price :
$35 *
At a glance
- Drugs Regadenoson (Primary)
- Indications Coronary disorders
- Focus Adverse reactions; Pharmacodynamics
- 02 Nov 2020 New trial record